BioLegend, a San Diego-based provider of biological reagents and tools, has opened a new global headquarters within the city that is designed to support future growth, provide a more attractive environment for staffers, and better serve customers worldwide.
The new 8-acre campus at 8999 BioLegend Way replaces the company’s previous home base in Sorrento Valley, on Pacific Heights Boulevard. BioLegend says its new HQ is designed to accommodate more than 1,000 employees.
“BioLegend is proud to be enabling discoveries that improve human health in cancer therapy, neuroscience, and immunology. Our new state-of-the-art campus allows us to expand the breadth and depth of our research and diagnostics portfolios to accelerate cures for debilitating diseases,” BioLegend president and CEO Gene Lay, DVM, who founded the company in 2002, said in a statement. “We look forward to creating new job opportunities for San Diego residents and growing our scientific talent base to meet our customers’ needs.”
Lay hosted an inaugural symposium marking the grand opening of the new headquarters on Wednesday. The symposium, which focused on cancer immunotherapy, included talks by five world-renowned immunologists—including 2018 Nobel Laureate, James P. Allison, PhD, of The University of Texas MD Anderson Cancer Center—and drew a crowd of 300 senior scientists, business leaders, and trusted partners.
The new headquarters has been designed as a sustainable facility, with features that include a green roof, solar panels, and electric charging stations in the parking structure. The new campus was also designed to enable greater collaboration between departments while providing efficient laboratories and workspaces for employees.
BioLegend’s new headquarters also includes San Diego’s first-ever installation of a robotic picking system, which is the first worldwide in a cold storage space. BioLegend said the new technologies will help it fulfill orders for customers more quickly and accurately.
BioLegend’s products are designed for use in research areas that include immunology, neuroscience, cancer, stem cells, and cell biology. BioLegend’s reagents are supported by the company’s customer service team, and a quality management system that is certified for ISO 13485:2016.
The company’s product development program produces strategic reagents for use in a variety of applications including:
- Flow cytometry and mass cytometry
- ELISA and ELISPOT
- Immunoprecipitation and ChIP
- Western blotting
- Immunofluorescence microscopy
- In vitro or in vivo functional assays
- Quantitative multiplexing
“BioLegend’s decision to build their campus here is a strong affirmation of San Diego’s role as a biotech hotbed. We look forward to BioLegend paving the way for more scientific discovery, creating more good-paying jobs for San Diegans, and building a brighter future for people across the globe,” added San Diego Mayor Kevin L. Faulconer (R).
Mayor Faulconer was among dignitaries at the grand opening, during which representatives from California’s 52nd Congressional District and San Diego City Council presented BioLegend with a Proclamation and a Commendation, respectively.